Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effect of LX3305 on methotrexate (MTX)
pharmacokinetics and to evaluate the safety and tolerability of LX3305 given over 14 days in
subjects with stable rheumatoid arthritis that are receiving stable doses of MTX.